PAMELA BALADI: Open Payments
NPI 1003593831 · RIVERDALE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,944 in 126 payments from 16 companies in 2025. Trend: 2023 $288 · 2024 $1,094 · 2025 $1,944
Food & beverage: $1,944
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $432 |
| Galderma Laboratories, L.P. | 19 | $264 |
| Arcutis Biotherapeutics, Inc. | 8 | $217 |
| GENZYME CORPORATION | 4 | $181 |
| Incyte Corporation | 20 | $176 |
| Regeneron Healthcare Solutions, Inc. | 9 | $147 |
| Botanix SB Inc | 8 | $144 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $75 |
| Janssen Biotech, Inc. | 4 | $74 |
| Amgen Inc. | 4 | $72 |
Products named: SKYRIZI, DUPIXENT, Zoryve, OPZELURA, NEMLUVIO, RINVOQ, SOFDRA, AKLIEF.
Industry payments across NJ — which companies pay providers there.
